Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing

AIDS

Volumn 12, Issue 12, 1998, Pages 1405-1412

  Nkengasong, John N ^a,e   Willems, Betty ^a   Janssens, Wouter ^a   Cheingsong Popov, Rachanee ^b,f   Heyndrickx, Leo ^a   Barin, Francis ^c   Ondoa, Pascale ^a   Fransen, Katrien ^a   Goudsmit, Jaap ^d   Van Der Groen, Guido ^a,g  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITÉ DE TOURS   (France)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e Projet RETRO CI   (Côte d’Ivoire)

^f NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^g NONE   (Belgium)

Author keywords

Genetic subtypes; Peptides; V3 loop peptide enzyme immunoassay subtyping

Indexed keywords

SYNTHETIC PEPTIDE;

ACCURACY; ARTICLE; BELGIUM; CONSENSUS SEQUENCE; CORRELATION FUNCTION; ENZYME IMMUNOASSAY; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR CLINICAL STUDY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SEROTYPING; VIRUS TYPING;

AMINO ACID SEQUENCE; GENES, ENV; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; SEROTYPING;

EID: 15144360872     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199812000-00001     Document Type: Article

References (25)

1. Delwart EL, Shpaer EG, Louwagie J, et al.: Genetic relationships determined by a DNA heteroduplex assay: analysis of HIV-1 env genes. Science 1993, 262:1257-1261.
2. Pieniazek D, Janini LM, Ramos A, et al.: HIV-1 patients may harbor viruses of different phylogenetic subtypes: implications for the evolution of the HIV/AIDS pandemic. Emerg Infect Dis 1995, 1:86-88.
3. Subbarao S, Luo C-C, Limpakarnjanarat K, et al.: Evaluation of oligonucleotide probes for the determination of the two major HIV-1 env subtypes in Thailand. AIDS 1996, 10:350-351.
4. Myers G, Korber B, Smith RF, Berzofsky JA, Pavlakis GN: Human Retroviruses and AIDS 1993. Los Alamos: Los Alamos National Laboratory; 1993.
5. Jansson M, Wahren B, Albert J, et al.: Peptide serology for analysis of the inter-and intra-individual variation in the HIV-1 V3 domain. AIDS 1994, 8:413-421.
6. Pau C-P, Lee-Thomas S, Auwanit W, et al.: Highly specific V3 peptide enzyme immunoassay for serotyping HIV-1 specimens from Thailand. AIDS 1993, 7:337-340.
7. Cheingsong-Popov R, Callow D, Beddows S, et al.: Serotyping HIV-1 by antibody binding to the V3-loop: relationship to viral genotype. AIDS Res Hum Retroviruses 1994, 10:1379-1386.
8. Pau C-P, Kai M, Holloman-Candal DL, et al.: Antigenic variation and serotyping of HIV-1 from four WHO-sponsored HIV vaccine sites. AIDS Res Hum Retroviruses 1994, 10:1369-1377.
9. Wasi C, Hering B, Raktham S, et al.: Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E. AIDS 1995, 9:843-849.
10. Peeters M, Nkengasong J, Willems B, et al.: Antibodies to V3-loop peptides derived from chimpanzee lentiviruses and the divergent HIV-1 ANT70 isolate in human sera from different geographic regions. AIDS 1994, 8:1657-1661.
11. Massangan M, Ndoyo J, Hu DJ, et al.: A highly heterogenous HIV-1 epidemic in the Central African Republic. Emerg Infect Dis 1996, 2:222-224.
12. Myers G, Korber B, Wain-Hobson S, Smith RF, Pavlakis GN: Human Retroviruses and AIDS 1992. Los Alamos: Los Alamos National Laboratory; 1992.
13. Myers G, Korber B, Wain-Hobson S, Jeang KT, Henderson L, Pavlakis GN: Human Retroviruses and AIDS 1994. Los Alamos: Los Alamos National Laboratory; 1994.
14. Barin F, Lahbabi Y, Buzelay L, et al.: Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping. AIDS Res Hum Retroviruses 1996, 12:1279-1289.
15. Fransen K, Buvé A, Nkengasong JN, Laga M, van der Groen C: Longstanding presence in Belgians of multiple non-B HIV-1 subtypes [letter]. Lancet 1996, 347:1403.
16. Heyndrickx L, Janssens W, Coppens S, et al.: HIV-1 C2V3 env diversity among Belgian individuals. AIDS Res Hum Retroviruses 1998 (in press).
17. Myers G, Korber B, Foley B, Jeang K-T, Mellors JW, Wain-Hobson S: Human Retroviruses and AIDS 1996. Los Alamos: Los Alamos National Laboratory; 1996:III-88-III-90.
18. Hoelscher M, Hanker S, Barin F, et al.: HIV-1 V3 serotyping in Tanzanian samples: possible reasons for mismatching with genetic subtyping. AIDS Res Hum Retroviruses 1998, 14:139-149.
19. Orloff GM, Kalish ML, Chiphangwi J, et al.: V3-loops of HIV-1 specimens from pregnant women in Malawi uniformly lack a potential N-linked glycosylation site. AIDS Res Hum Retroviruses 1993, 9:705-706.
20. Korber B, Macinnes K, Smith RF, Myers G: Mutational trends in V3-loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J Virol 1994, 68:6730-6744.
21. Cheingsong-Popov R, Osmanov S, Pau C-P, et al.: Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization. AIDS Res Hum Retroviruses 1998, 14:311-318.
22. Nkengasong J, Janssens W, Heyndrickx L, et al.: Genotypic sub-types of HIV-1 in Cameroon. AIDS 1994, 8:1405-1412.
23. Nkengasong J, Abouya L, Coulibaly D, et al.: Genetic diversity of HIV-1 in Côte d'Ivoire: comparison of a V3-loop peptide enzyme immunoassay and a restriction fragment length polymorphism test. X International Conference on AIDS and STD in Africa. Abidjan, December 1997 [abstract A402].
24. Cheingsong-Popov R, Williamson C, Lister S, et al.: Usefulness of HIV-1 V3-loop serotyping in studying the HIV-1 epidemic in South Africa. AIDS 1998, 12:949-950.
25. Nyambi P, Lewi P, Peeters M, et al.: Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant. J Virol 1997, 71:2320-2330.